Why your manuscript was rejected and how to prevent it?

Why your manuscript was rejected and how to prevent it?

Dogra S. Why your manuscript was rejected and how to prevent it? Indian J Dermatol Venereol Leprol;77:123-7. For students of health sciences, young professionals or anyone who is writing for the first time, this article helps understand why a manuscript is rejected. The author gives a list of common reasons and also several points with crisp explanation as to how to avoid rejection. Two most important points that he mentions are to follow the "Instructions to authors" meticulously (it is surprising that many often do not!) and to have a positive attitude towards learning from reviewers' comments. Appeared in QMedCONNECT…
Read More
Miles to go before we sleep: education, technology, and the changing paradigms in health information

Miles to go before we sleep: education, technology, and the changing paradigms in health information

Cleveland AD Miles to go before we sleep: education, technology, and the changing paradigms in health information* J Med Libr Assoc. 2011 January; 99(1): 61–69 The author discusses the urgent need to upgrade health information based degrees where she stresses that while the important principles of library science need to be taught, the curriculum should now include concepts of healthcare as well as other information centred disciplines. In India, it is not about "upgrading", as we do not have a health information degree; we have Library & Information Sciences as a broad discipline. What we need for our medical colleges…
Read More
Goodbye PubMed, hello raw data

Goodbye PubMed, hello raw data

Godlee F. Goodbye PubMed, hello raw data BMJ 2011; 342:d212 The editor of BMJ writes about the H1N1 influenza epidemic in the last year and discusses about the effectiveness of antivirals and the drug oseltamivir. She quotes another BMJ article (BMJ 2011; 342:c7258) where the authors Jefferson and Doshi, who were reviewers of a Cochrane review on the same topic, were unable to get the data from the trial that they covered they needed to validate their conclusion about the efficacy of the antiviral. She goes on to explain that these reviewers while compiling a list of trials located a…
Read More